Journal of the American Medical Informatics Association · 2008 · 61 citations · 26 references
PharmacyHealth InformaticsPreventive MedicineDisease SurveillancePatient SafetyPharmacovigilanceAdverse Drug Event DetectionAdverse Drug Event PreventionAdverse Drug Reaction DetectionAdverse Drug Reaction MonitoringDrug Safety MonitoringHospital SurveillanceAdverse Drug EventsAdverse Drug Reaction SurveillanceAdverse Event DetectionDrug Safety SurveillanceMonitorsSerious Adverse Event DetectionSurveillance Systems
OBJECTIVE: Computerized monitors can effectively detect and potentially prevent adverse drug events (ADEs). Most monitors have been developed in large academic hospitals and are not readily usable in other settings. We assessed the ability of a commercial program to identify and prevent ADEs in a community hospital. DESIGN: and Measurement We prospectively evaluated the commercial application in a community-based hospital. We examined the frequency and types of alerts produced, how often they were associated with ADEs and potential ADEs, and the potential financial impact of monitoring for ADEs. RESULTS: Among 2,407 patients screened, the application generated 516 high priority alerts. We were able to review 266 alerts at the time they were generated and among these, 30 (11.3%) were considered substantially important to warrant contacting the physician caring for the patient. These 30 alerts were associated with 4 ADEs and 11 potential ADEs. In all 15 cases, the responsible physician was unaware of the event, leading to a change in clinical care in 14 cases. Overall, 23% of high priority alerts were associated with an ADE (95% confidence interval [CI] 12% to 34%) and another 15% were associated with a potential ADE (95% CI 6% to 24%). Active surveillance used approximately 1.5 hours of pharmacist time daily. CONCLUSIONS: A commercially available, computer-based ADE detection tool was effective at identifying ADEs. When used as part of an active surveillance program, it can have an impact on preventing or ameliorating ADEs.
26
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Incidence of Adverse Drug Events and Potential Adverse Drug Events
David W. Bates · JAMA · 1995 · 2.1K citations